Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-26 00:00:00 ET · period of report 2022-10-24 · accession 0000899243-22-034281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-26 | 2022-10-24+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.56 | -393.9K | 23.77M | -2% | -$1.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-24 | S | D | 206,504 | $2.48 | 23,954,637 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-10-25 | S | D | 187,442 | $2.64 | 23,767,195 | D | — | — |